Effects of levosimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure. by Parissis, J, Adamopoulos, S, Antoniades, C, Kostakis, G, Rigas, A, Kyrzopoulos, S, Iliodromitis, E, Kremastinos, D